A survival model for patients with ccRCC based on four of these genes (CD44, DPP4, NCOA4, and SLC7A11) demonstrated excellent prognostic efficacy, and risk scoring was an independent factor for prognosis prediction (102). This evidence concerns the gene NCOA4 and nonpapillary renal cell carcinoma.